$74.32
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing
Disc Medicine Insider Sold Shares Worth $2,387,296, According to a Recent SEC Filing
Disc Medicine Insider Sold Shares Worth $1,287,801, According to a Recent SEC Filing
Overview
52-week range
$40
$100
58% of range
Avg surprise (last 3)
-14.8%
Avg reaction (last 2)
+1.1%
50% positive
Latest IV / EM
50%
EM ±11.5% · $75 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-1.65 | $-1.55 | -6.5% | -61.8% | -0.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.77 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-1.58 | $-1.17 | -35.0% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-1.02 | $-0.99 | -3.0% | — | +2.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.89 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.03 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.09 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.58 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.74 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$1.58 | -$1.58 | 0.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-70M | — | $-68M | $-61M | $-40M | — | $-33M | $-31M |
| Net income | $-64M | — | $-62M | $-55M | $-34M | — | $-27M | $-26M |
| EPS (diluted) | $-1.65 | — | $-1.77 | $-1.58 | $-1.02 | — | $-0.89 | $-1.03 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $89M | $91M | $141M | $127M | $123M | $192M | $193M | $281M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $747M | $804M | $627M | $662M | $706M | $494M | $493M | $508M |
| Total assets | $750M | $807M | $630M | $665M | $709M | $497M | $495M | $510M |
| Long-term debt | $29M | $29M | $29M | $29M | $29M | $28M | — | — |
| Total liabilities | $62M | $67M | $57M | $51M | $49M | $53M | $27M | $21M |
| Total equity | $688M | $740M | $573M | $614M | $660M | $444M | $468M | $489M |